Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

Global Response Against Superbugs and Pathogens

Project description

Responding to the global antimicrobial resistance crisis

Antimicrobial resistance (AMR) poses serious global socio-economic challenges. Antibiotic-resistant pathogens lead to increased economic losses and higher mortality rates. The United Nations indicates that climate change affects the diversity of AMR genes, influencing bacterial growth and mutation. Supported by the Marie Skłodowska-Curie Actions programme, the GRASP project will address the AMR crisis through various synergistic approaches, including studying essential enzymes and virulence factors, drug repurposing, and phage therapy. It will investigate how DNA repair defects contribute to AMR in clinical strains of Mycobacterium and Helicobacter pylori. Additionally, the project will develop practical case studies on AMR stewardship and create new computational and AI-based models to study AMR emergence in natural and clinical settings.

Objective

The emergence and spread of AMR are major socio-economic problems in Europe and worldwide. The epidemic of antibiotic-resistant pathogens, particularly in healthcare settings, is associated with increased costs in terms of economic losses and human suffering, as well as increased rates of mortality and morbidity. Moreover, the United Nations has recently reported that the diversity and abundance of environmental antimicrobial resistance genes are also modulated by climate change, as increased temperature acts as a driver of AMR by modulating bacterial growth, metabolism, mutation rates, and horizontal gene transfer.

The GRASP project will address the AMR crisis at several different levels. We will develop different synergistic approaches to target AMR including chemical biology of essential enzymes and virulent factors, drug repurposing, and phage therapy. Moreover, to understand the emergence and spreading of AMR, we are particularly interested in understanding how DNA repair defects can drive the emergence of AMR in the clinical strains of Mycobacterium and Helicobacter pylori. Finally, we are also interested in developing concrete case studies with more applied interest e.g in AMR stewardship, and the development of new computational and AI-based models as well as experimental devices to study the emergence of AMR in Nature and clinics.

The highly complementary GRASP consortium includes specific expertise provided by leading European, North American, and African partners that will together build synergistic interactions to address the global health crisis. The private sector will actively provide supervision, mentoring, and various expertise in lab automation, nanofabrication, scientific instrumentation, AI methods, and computational biology. GRASP will thus provide researchers and technicians with new skill sets to advance their career perspectives and networking opportunities.

Fields of science (EuroSciVoc)

Keywords

Programme(s)

Topic(s)

Funding Scheme

HORIZON-TMA-MSCA-SE - HORIZON TMA MSCA Staff Exchanges

See all projects funded under this funding scheme

Call for proposal

(opens in new window) HORIZON-MSCA-2024-SE-01

See all projects funded under this call

Coordinator

ECOLE POLYTECHNIQUE
Net EU contribution
€ 415 830,00
Address
ROUTE DE SACLAY
91128 PALAISEAU CEDEX
France
Region
Ile-de-France Ile-de-France Paris
Activity type
Higher or Secondary Education Establishments
Links
Total cost
No data

Participants (7)

Partners (7)